ELPEN Pharmaceutical Co. Inc.

Elpen is the leading greek pharmaceutical company with presence in more than 90 countries. The company develops and produces branded generics and value added medicines across different technologies and therapeutic areas, investing more than 10% of its annual turnover into Research & Development. Since 2012, the company has established ELPEN Pharma GmbH, a subsidiary in Germany and in 2024 established its subsidiary in Dubai.